comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 22:05:41 - browse：54

What difference does a day make? Who gets to have gene therapy? And are biotech startups OK?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays. Then, HSBC Managing Director Jonathan Norris calls in to discuss why so many biotech startups are facing financial bridges to nowhere.

For more on what we cover, here’s the story on gene therapy; here’s more on Ipsen’s treatment for FOP; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Medicare isn't yet testing food as medicine

WSS

Pfizer is about to make a big push in cancer. Will investors listen?

Pfizer is about to make a big push in cancer. Will investors listen?

Redefining sustainability for the pharmaceutical industry

CDC advisory group OKs chikungunya vaccine

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Wikipedia

comprehensive

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

AI used to predict Covid

Duchenne breakthrough therapy leaves behind pioneering families

Prosthetic arm enables patients to feel the objects they grip

United colonoscopy coverage change 'may cost lives,' doctors say

Dark money group runs ads on China biotech bill

Alkermes shareholders re

CDC panel: People 65 and older should get a Covid spring booster shot

explore

Adam's Biotech Scorecard: Do Sarepta's exon

Report: NIH

Biohaven protein

Heat waves linked to early deliveries, preterm births in new study

AI used to predict Covid

Are embryos people? Reproductive medicine's future depends on the answer

focus

focus

entertainment

knowledge